Chamomile and Cancer: What Science Reveals Today

Chamomile has been utilized for hundreds of years for sleep disorders, upset stomach, and chronic inflammatory conditions. Lately, scientific inquiry has expanded into its promising anticancer activity. Controlled lab experiments have demonstrated that certain phytochemicals in chamomile—particularly the compounds apigenin and luteolin—may inhibit the growth of cancer cells in cell cultures. These flavonoids appear to disrupt biological processes that enable cancer cells to spread rapidly. For instance suggests that apigenin can induce apoptosis—programmed cell death—in cancerous tissue while leaving intact healthy cells. The documented outcomes have been noted in cell lines derived from cancers of the breast, prostate, skin, and GI tract. It’s crucial to recognize, these findings were generated in non-human systems and may not directly reflect the same outcomes in clinical populations. Human studies involving chamomile derivatives in oncology populations remain extremely scarce. While consuming chamomile tea or chamomile supplements is typically well-tolerated for healthy adults, https://asresalamat.ir/7-properties-of-chamomile-tea-what-is-chamomile-tea-good-for/ (visit your url) they should never replace standard cancer therapies. Investigations are ongoing to explore whether chamomile compounds could enhance established cancer protocols or alleviate treatment-related side effects such as inflammation and DNA-impairing oxidative damage. Well-designed human clinical trials are urgently needed to ascertain whether chamomile can contribute meaningfully in lowering tumor incidence or therapeutic intervention. For now, chamomile remains a fascinating area of study—but not an established treatment.